A Kurihara

Author PubWeight™ 31.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lumbar spinal stenosis and nerve root entrapment syndromes. Definition and classification. Clin Orthop Relat Res 1976 2.25
2 Three-dimensional evaluation of upper airway in patients with different anteroposterior skeletal patterns. Orthod Craniofac Res 2013 1.97
3 p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity. Oncogene 2007 1.56
4 Minimum 10-year outcome of decompressive laminectomy for degenerative lumbar spinal stenosis. Spine (Phila Pa 1976) 2000 1.41
5 Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res 2000 1.31
6 Lumbar disc herniation in children and adolescents. A review of 70 operated cases and their minimum 5-year follow-up studies. Spine (Phila Pa 1976) 1981 1.09
7 The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy. Diabetes Res Clin Pract 1994 1.05
8 The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite. J Thromb Haemost 2007 1.03
9 Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel. Xenobiotica 2009 1.00
10 Reduction by dexamethasone of chemotactic activity in inflammatory exudates. Eur J Pharmacol 1984 0.92
11 Delayed-type hypersensitivity as revealed on the footpads of mice to azobenzenearsonate-acetyl bovine serum albumin. Int Arch Allergy Appl Immunol 1981 0.90
12 The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology 1992 0.88
13 Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency. Neurology 2002 0.87
14 Mechanisms of anti-inflammatory action of dexamethasone: blockade by hydrocortisone mesylate and actinomycin D of the inhibitory effect of dexamethasone on leukocyte infiltration in inflammatory sites. J Pharmacol Exp Ther 1984 0.87
15 p51/p63 Inhibits ultraviolet B-induced apoptosis via Akt activation. Oncogene 2007 0.86
16 Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion. Clin Pharmacol Ther 2010 0.86
17 Dexamethasone inhibits generation in inflammatory sites of the chemotactic activity attributable to leukotriene B4. Biochem Biophys Res Commun 1984 0.86
18 Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication. Neurology 2002 0.84
19 Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs. Xenobiotica 2009 0.82
20 Chemotactic factor production by rat polymorphonuclear leukocytes: stimulation with opsonized zymosan particles and inhibition by dexamethasone. Biochem Biophys Res Commun 1984 0.81
21 Absorption, distribution and excretion of the new thienopyridine agent prasugrel in rats. Xenobiotica 2007 0.81
22 Prediction of pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in humans using animal data. Xenobiotica 2007 0.81
23 Correlation of leukocyte accumulation with chemotactic activity in the exudate of an allergic air-pouch inflammation. Int Arch Allergy Appl Immunol 1983 0.81
24 Highly frequent anti-idiotype antibody in cynomolgus monkeys developed against mouse-derived regions of anti-Fas antibody humanized by complementarity determining region grafting. Br J Pharmacol 2009 0.80
25 The adverse effect of commercial dentine-bonding systems on the skin of guinea pigs. J Oral Rehabil 1998 0.80
26 Spontaneous spinal subdural hematoma. A case report. Spine (Phila Pa 1976) 1984 0.80
27 Cervical myelopathy with Prader-Willi syndrome in a 13-year-old boy. A case report. Spine (Phila Pa 1976) 1991 0.79
28 Nucleosides and nucleotides. 141. Chemical stability of a new antitumor nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in alkaline medium: formation of 2'-C-cyano-2'-deoxy-1-beta-D-ribo-pentofuranosylcytosine and its antitumor activity. J Med Chem 1995 0.78
29 Analysis of the effect of an anti-inflammatory steroid, dexamethasone, on neutrophil chemotaxis in the Boyden chamber with a modified 51Cr-labeling method. J Pharmacobiodyn 1984 0.77
30 Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker. Bioconjug Chem 1999 0.77
31 Disposition and metabolic fate of prasugrel in mice, rats, and dogs. Xenobiotica 2007 0.77
32 Longitudinal ruptures of the peroneal tendons. A report of a rugby player. Acta Orthop Scand 1991 0.77
33 Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats. Xenobiotica 2009 0.77
34 Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium. Jpn J Pharmacol 1995 0.76
35 [Plasma cascade filtration therapy in a case of subacute cerebellar degeneration associated with Eaton-Lambert type of neuromuscular block]. Rinsho Shinkeigaku 1986 0.75
36 [So-called lumbar spinal canal stenosis]. Seikei Geka 1972 0.75
37 Adverse effect of dentine bonding agent on the oral mucosa of guinea pigs. J Oral Rehabil 2001 0.75
38 [Percutaneous cryosurgery for liver tumors]. Gan To Kagaku Ryoho 2001 0.75
39 In vitro metabolism of human and salmon calcitonins in rat liver and kidney evaluated by liquid chromatography-tandem mass spectrometry. Xenobiotica 2000 0.75
40 Application of the bromophenol blue (BPB) staining method to rat fetal cartilage previously stained with alizarin red S. Jikken Dobutsu 1993 0.75
41 [Method for attaching the artificial limb immediately after amputation]. Seikei Geka 1968 0.75
42 [Changes in coagulation inhibitors (AT III, protein C, protein S) in patients with liver cirrhosis]. Rinsho Byori 1989 0.75
43 Investigation of usefulness of sperm analyses in dogs for male fertility study. J Toxicol Sci 2001 0.75
44 [Intra-arterial infusion of CDDP in advanced gastrointestinal cancer (combination of general chemotherapy)]. Gan To Kagaku Ryoho 1986 0.75
45 Amidolytic kinetic assay of protein C by selective spectrophotometry in a centrifugal analyzer. Clin Chem 1988 0.75
46 [Fundamental study and clinical application of cortisol kit "DAINABOT" (author's transl)]. Horumon To Rinsho 1982 0.75
47 [Surgical therapy of refractory whiplash injuries]. Seikei Geka 1969 0.75
48 [Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia]. Rinsho Ketsueki 1989 0.75
49 Pharmacokinetics of loxoprofen and its active metabolite after dermal application of loxoprofen gel to rats. Pharmazie 2015 0.75
50 The experimental and clinical studies of deproteinized calf bone transplantation. Kobe J Med Sci 1965 0.75
51 Effects of sematilide, a novel class III antiarrhythmic agent, on membrane currents in rabbit atrial myocytes. Eur J Pharmacol 1997 0.75
52 [Chronic inflammatory demyelinating polyneuropathy in childhood]. No To Shinkei 1993 0.75
53 The surgical treatment of myelopathy secondary to rheumatoid arthritis of the lower cervical spine. Int Orthop 1979 0.75
54 Effects of sematilide, a novel class III antiarrhythmic agent, on delayed rectifier K+ current in guinea pig atrial myocytes. Jpn J Pharmacol 1996 0.75
55 Variant forms of glucokinase gene in Japanese patients with late-onset type 2 diabetes. Acta Diabetol 1994 0.75
56 [Four cases of reversible posterior leukoencephalopathy syndrome]. No To Hattatsu 2001 0.75
57 [Case of neurogenic arthropathy of the shoulder joint]. Seikei Geka 1967 0.75
58 [Selection of internal fixation materials for fracture]. Geka Chiryo 1967 0.75
59 [Sensory nerve conduction velocity determined by somatosensory evoked potentials in patients with hereditary motor and sensory neuropathy type I]. Rinsho Shinkeigaku 1995 0.75
60 [Neurogenic joint diseases. 1. Clinical studies]. Nihon Seikeigeka Gakkai Zasshi 1971 0.75
61 [Nursing of a child with traumatic cataract]. Kango Gijutsu 1974 0.75
62 Cauda equina tumor causing increased intracranial pressure. Kobe J Med Sci 1986 0.75
63 [Neurogenic joint diseases. 2. Histopathological studies]. Nihon Seikeigeka Gakkai Zasshi 1971 0.75
64 Pharmacokinetics of RU44403, an active form of newly developed angiotensin-converting enzyme inhibitor (RU44570) in the rat. Drug Metab Dispos 1994 0.75
65 Prediction of human pharmacokinetics of panipenem, a new carbapenem antibiotic, from animal data. Drugs Exp Clin Res 1992 0.75
66 Effects of a single drip infusion of lipo-prostaglandin E1 on vibratory threshold in patients with diabetic neuropathy. Prostaglandins 1995 0.75